Stock chart
Ticker: ANIP Exchange: NMS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Total value Details
2024-05-17 2024-05-17 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
1,000 -0.8%
62.09
100,000 USD
1,000 -0.8% 62.09 100,000 USD
2024-05-17 2024-05-16 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
1,000 -2.1%
63.84
100,000 USD
1,000 -2.1% 63.84 100,000 USD
2024-05-17 2024-05-16 S Sale

TANNENBAUM RENEE P

Non-Executive Director
1,000 -9.9%
63.87
100,000 USD
1,000 -9.9% 63.87 100,000 USD
2024-05-17 2024-05-15 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
1,000 -1.9%
65.86
100,000 USD
1,000 -1.9% 65.86 100,000 USD
2024-05-13 2024-05-13 PS Planned sale

Cook Meredith

SR. VP, GENERAL COUNSEL & SEC.

Officer
1,000 -0.4%
67.69
100,000 USD
1,000 -0.4% 67.69 100,000 USD
2024-05-03 2024-05-01 PS Planned sale

Gassert Chad

SVP - CORP. DEV. & STRATEGY

Officer
20,000 -7.9%
66.62
1,332,400 USD
20,000 -7.9% 66.62 1,332,400 USD
2024-04-22 2024-04-19 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
16,809 -2.1%
65.17
1,095,443 USD
16,809 -2.1% 65.17 1,095,443 USD
2024-04-22 2024-04-18 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
10,423 -1.3%
64.98
677,287 USD
10,423 -1.3% 64.98 677,287 USD
2024-04-17 2024-04-17 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
9,520 -1.2%
65.40
622,608 USD
9,520 -1.2% 65.40 622,608 USD
2024-04-17 2024-04-16 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
5,834 -0.7%
66.20
386,211 USD
5,834 -0.7% 66.20 386,211 USD
2024-04-17 2024-04-15 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
7,414 -0.9%
66.33
491,771 USD
7,414 -0.9% 66.33 491,771 USD
2024-04-15 2024-04-12 PS Planned sale

Cook Meredith

SR. VP, GENERAL COUNSEL & SEC.

Officer
250 -0.4%
67.79
16,948 USD
250 -0.4% 67.79 16,948 USD
2024-04-02 2024-04-01 PS Planned sale

Gassert Chad

SVP - CORP. DEV. & STRATEGY

Officer
20,000 -7.3%
67.25
1,345,000 USD
20,000 -7.3% 67.25 1,345,000 USD
2024-03-13 2024-03-13 PS Planned sale

Cook Meredith

SR. VP, GENERAL COUNSEL & SEC.

Officer
250 -0.4%
66.54
16,635 USD
250 -0.4% 66.54 16,635 USD
2024-03-13 2024-03-11 PS Planned sale

Gassert Chad

SVP - CORP. DEV. & STRATEGY

Officer
20,000 -6.8%
65.81
1,316,200 USD
20,000 -6.8% 65.81 1,316,200 USD
2024-03-11 2024-03-11 S Sale

CAREY STEPHEN P.

SVP & CFO

Officer
7,787 -4.2%
65.55
510,438 USD
7,787 -4.2% 65.55 510,438 USD
2024-03-11 2024-03-08 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
10,000 -1.2%
67.17
671,700 USD
10,000 -1.2% 67.17 671,700 USD
2024-03-08 2024-03-08 S Sale

Lalwani Nikhil

PRESIDENT & CEO

Executive Director
16,292 -3.8%
67.13
1,093,682 USD
16,292 -3.8% 67.13 1,093,682 USD
2024-03-07 2024-03-07 S Sale

Marken James G.

SVP OPS & PROD DEV

Officer
24,338 -16.4%
66.37
1,615,313 USD
24,338 -16.4% 66.37 1,615,313 USD
2024-03-07 2024-03-07 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
15,085 -1.8%
66.35
1,000,890 USD
15,085 -1.8% 66.35 1,000,890 USD
2024-03-08 2024-03-06 S Sale

Lalwani Nikhil

PRESIDENT & CEO

Executive Director
28,965 -6.1%
65.52
1,897,787 USD
28,965 -6.1% 65.52 1,897,787 USD
2024-03-07 2024-03-06 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
14,822 -1.7%
65.47
970,396 USD
14,822 -1.7% 65.47 970,396 USD
2024-03-07 2024-03-05 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
10,093 -1.1%
65.35
659,578 USD
10,093 -1.1% 65.35 659,578 USD
2024-03-06 2024-03-05 S Sale

Mutz Christopher

HEAD OF RARE DISEASE

Officer
5,000 -5.4%
66.00
330,000 USD
5,000 -5.4% 66.00 330,000 USD
2024-03-06 2024-03-04 S Sale

Pera Antonio R

Non-Executive Director
7,000 -20.8%
65.20
456,400 USD
7,000 -20.8% 65.20 456,400 USD
2024-02-13 2024-02-13 PS Planned sale

Cook Meredith

SR. VP, GENERAL COUNSEL & SEC.

Officer
250 -0.7%
56.04
14,010 USD
250 -0.7% 56.04 14,010 USD
2024-01-23 2024-01-23 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
15,000 -1.7%
56.44
846,600 USD
15,000 -1.7% 56.44 846,600 USD
2024-01-23 2024-01-22 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
5,692 -0.6%
55.95
318,467 USD
5,692 -0.6% 55.95 318,467 USD
2024-01-23 2024-01-19 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
4,524 -0.5%
55.57
251,399 USD
4,524 -0.5% 55.57 251,399 USD
2024-01-18 2024-01-18 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
9,784 -1.1%
55.30
541,055 USD
9,784 -1.1% 55.30 541,055 USD
2024-01-18 2024-01-17 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
10,000 -1.1%
55.11
551,100 USD
10,000 -1.1% 55.11 551,100 USD
2024-01-18 2024-01-16 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
5,000 -0.5%
55.63
278,150 USD
5,000 -0.5% 55.63 278,150 USD
2024-01-16 2024-01-12 PS Planned sale

Cook Meredith

SR. VP, GENERAL COUNSEL & SEC.

Officer
250 -0.7%
56.43
14,108 USD
250 -0.7% 56.43 14,108 USD
2023-12-19 2023-12-19 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
25,000 -2.6%
52.65
1,316,250 USD
25,000 -2.6% 52.65 1,316,250 USD
2023-12-19 2023-12-18 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
13,026 -1.3%
52.44
683,083 USD
13,026 -1.3% 52.44 683,083 USD
2023-12-19 2023-12-15 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
11,974 -1.2%
52.44
627,917 USD
11,974 -1.2% 52.44 627,917 USD
2023-12-11 2023-12-11 PS Planned sale

Cook Meredith

SR. VP, GENERAL COUNSEL & SEC.

Officer
250 -0.7%
49.21
12,303 USD
250 -0.7% 49.21 12,303 USD
2023-11-20 2023-11-17 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
13,000 -1.3%
51.00
663,000 USD
13,000 -1.3% 51.00 663,000 USD
2023-11-16 2023-11-16 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
6,448 -0.6%
51.66
333,104 USD
6,448 -0.6% 51.66 333,104 USD
2023-11-16 2023-11-15 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
7,647 -0.8%
53.64
410,185 USD
7,647 -0.8% 53.64 410,185 USD
2023-11-16 2023-11-15 S Sale

Davis Krista

SVP, CHIEF HR OFFICER

Officer
2,622 -7.4%
53.81
141,090 USD
2,622 -7.4% 53.81 141,090 USD
2023-11-16 2023-11-14 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
22,095 -2.1%
53.17
1,174,791 USD
22,095 -2.1% 53.17 1,174,791 USD
2023-11-14 2023-11-13 PS Planned sale

Cook Meredith

SR. VP, GENERAL COUNSEL & SEC.

Officer
250 -0.7%
52.03
13,008 USD
250 -0.7% 52.03 13,008 USD
2023-11-13 2023-11-10 S Sale

Mutz Christopher

HEAD OF RARE DISEASE

Officer
3,000 -4.5%
52.47
157,410 USD
3,000 -4.5% 52.47 157,410 USD
2023-10-19 2023-10-19 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
10,000 -1.0%
57.06
570,600 USD
10,000 -1.0% 57.06 570,600 USD
2023-10-19 2023-10-18 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
6,242 -0.6%
57.78
360,663 USD
6,242 -0.6% 57.78 360,663 USD
2023-10-19 2023-10-17 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
8,758 -0.8%
58.53
512,606 USD
8,758 -0.8% 58.53 512,606 USD
2023-10-17 2023-10-16 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
13,063 -1.2%
58.31
761,704 USD
13,063 -1.2% 58.31 761,704 USD
2023-10-17 2023-10-13 PS Planned sale

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

Executive Director
11,937 -1.1%
57.58
687,332 USD
11,937 -1.1% 57.58 687,332 USD